Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma

University of Oklahoma · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
clear cell renal cell carcinoma, stereotactic body radiation therapy (sbrt), oligo metastatic, ctdna, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1008699
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.